Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed GlioblastomaCIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: CompletedReview Status: Completed
